Prostaglandin E 2 inhibits matrix mineralization by human bone marrow stromal cell-derived osteoblasts via Epac-dependent cAMP signaling

The osteoinductive properties of prostaglandin E (PGE ) and its signaling pathways have led to suggestions that it may serve as a potential therapeutic strategy for bone loss. However, the prominence of PGE as an inducer of bone formation is attributed primarily to findings from studies using rodent...

Full description

Saved in:
Bibliographic Details
Published in:Scientific reports 2017-05, Vol.7 (1), p.2243
Main Authors: Mirsaidi, Ali, Tiaden, André N, Richards, Peter J
Format: Article
Language:English
Subjects:
Adipogenesis - drug effects
Calcification, Physiologic - drug effects
Cells, Cultured
Cyclic AMP - metabolism
Dinoprostone - metabolism
Dinoprostone - pharmacology
Extracellular Matrix - metabolism
Guanine Nucleotide Exchange Factors - metabolism
Humans
Mesenchymal Stem Cells - metabolism
Models, Molecular
Osteoblasts - metabolism
Osteogenesis - drug effects
Receptors, Prostaglandin E, EP2 Subtype - metabolism
Receptors, Prostaglandin E, EP4 Subtype - metabolism
Signal Transduction
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The osteoinductive properties of prostaglandin E (PGE ) and its signaling pathways have led to suggestions that it may serve as a potential therapeutic strategy for bone loss. However, the prominence of PGE as an inducer of bone formation is attributed primarily to findings from studies using rodent models. In the current study, we investigated the effects of PGE on human bone marrow stromal cell (hBMSC) lineage commitment and determined its mode of action. We demonstrated that PGE treatment of hBMSCs significantly altered the expression profile of several genes associated with osteoblast differentiation (RUNX2 and ALP) and maturation (BGLAP and MGP). This was attributed to the activation of specific PGE receptors, and was associated with increases in cAMP production and sustained AKT phosphorylation. Pharmacological inhibition of exchange protein directly activated by cAMP (Epac), but not protein kinase A (PKA), recovered the mineralization functions of hBMSC-derived osteoblasts treated with PGE and restored AKT phosphorylation, along with the expression levels of RUNX2, ALP, BGLAP and MGP. Our findings therefore provide insights into how PGE influences hBMSC-mediated matrix mineralization, and should be taken into account when evaluating the role of PGE in human bone metabolism.
ISSN:2045-2322